Clinical Trial Update: A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is studying the effects of NNC0194-0499 alone or with semaglutide on blood sugar control in people with Type 1 diabetes; the study is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0194-0499
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: ACTIVE_NOT_RECRUITING